Get started
Author

David Lukas Wachter

Observed names: D L Wachter, D Wachter, D. L. Wachter, D. Wachter, D.L. Wachter, DL Wachter, David L Wachter, David L. Wachter, David Wachter, David-Lukas Wachter
Observed institutions: BC Cancer Agency, University of Bonn, University of British Columbia, University of California, Los Angeles, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Bonn, LMU Klinikum, Universitätsklinikum Erlangen, Klinikum Weiden, Comprehensive Cancer Center Erlangen, University Hospital Carl Gustav Carus, Pathologisches Institut, Heinrich Heine University Düsseldorf, Ludwig-Maximilians-Universität München
OpenAlex ID: A5108512295
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
2010 · Xiaohong R. Yang, Jenny Chang-Claude, et al. · JNCI Journal of the National Cancer Institute · 691
PDF
Dose-Response Association of CD8 + Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
2017 · Ellen L. Goode, Matthew S. Block, et al. · JAMA Oncology · 394
PDF
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
2011 · Peter A Fasching, Katharina Heusinger, et al. · BMC Cancer · 328
PDF
DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
2016 · Andrew E Teschendorff, Yang Gao, et al. · Nature Communications · 252
PDF
SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma
2014 · Abbas Agaimy, Michael Koch, et al. · The American Journal of Surgical Pathology · 169
On a dark-field signal generated by micrometer-sized calcifications in phase-contrast mammography
2013 · Thilo Michel, Jens Rieger, et al. · Physics in Medicine and Biology · 128
Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant
2015 · Johanna D. Strehl, David L. Wachter, et al. · Annals of Diagnostic Pathology · 120
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
2014 · AOCS Study Group, M Köbel, et al. · British Journal of Cancer · 110
PDF
Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets
2012 · Pamela L. Strissel, Matthias Ruebner, et al. · Oncotarget · 88
PDF
Impaired cell fusion and differentiation in placentae from patients with intrauterine growth restriction correlate with reduced levels of HERV envelope genes
2010 · Matthias Ruebner, Pamela L. Strissel, et al. · Journal of Molecular Medicine · 88
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
2018 · Paul Gass, Michael P. Lux, et al. · BMC Cancer · 83
PDF
Diabetes and prognosis in a breast cancer cohort
2010 · Michael G. Schrauder, Peter A. Fasching, et al. · Journal of Cancer Research and Clinical Oncology · 67
Breast Cancer Risk – Genes, Environment and Clinics
2011 · P. Fasching, A. Ekici, et al. · Geburtshilfe und Frauenheilkunde · 66
PDF
Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening
2018 · Lisa Siegler, Ramona Erber, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 65
Invasive Breast Cancer: Recognition of Molecular Subtypes
2011 · Johanna D. Strehl, David L. Wachter, et al. · Breast Care · 56
PDF
Adenomatoid tumors of the female and male genital tract. A comparative clinicopathologic and immunohistochemical analysis of 47 cases emphasizing their site-specific morphologic diversity
2011 · David L. Wachter, Peter H. Wünsch, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 55
Retransplantation of Cryopreserved Ovarian Tissue
2012 · Andreas Müller, Katja Keller, et al. · Deutsches Ärzteblatt international · 52
Grating-based darkfield imaging of human breast tissue
2013 · Gisela Anton, Florian Bayer, et al. · Zeitschrift für Medizinische Physik · 51
PDF
Diagnostic Value of Immunohistochemical IMP3 Expression in Core Needle Biopsies of Pancreatic Ductal Adenocarcinoma
2011 · David Lukas Wachter, Anne Schlabrakowski, et al. · The American Journal of Surgical Pathology · 49
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
2014 · David L. Wachter, Arndt Hartmann, et al. · BioMed Research International · 48
PDF
Akt and p53 are potential mediators of reduced mammary tumor growth by Chloroquine and the mTOR inhibitor RAD001
2011 · Christian R. Loehberg, Pamela L. Strissel, et al. · Biochemical Pharmacology · 48
Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer
2012 · C. Rauh, C. Hack, et al. · Geburtshilfe und Frauenheilkunde · 45
PDF
Xenotransplantation of cryopreserved ovarian tissue from patients with ovarian tumors into SCID mice—no evidence of malignant cell contamination
2011 · Laura Lotz, Markus Montag, et al. · Fertility and Sterility · 39
PDF
Insulin‐like growth factor II mRNA‐binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value
2011 · David L Wachter, Glen Kristiansen, et al. · Histopathology · 38
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
2015 · Stefanie Burghaus, Lothar Häberle, et al. · BMC Cancer · 36
PDF
Works count: 115
Citation count: 3,905
H-index: 30
I10-index: 55
Year
Topic
Type